Open Menu
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
PORIB Foundation
CONTACT
|
PORIB web
|
HOME
COMPANY
About us
PORIB team
Mission-Values
SERVICES
Health Economic Evaluation
Pricing and Reimbursement
Market Access
Real-World Evidence
Scientific Communication
Healthcare Management
Advisory Boards
Biostatistics
Training
CUSTOMERS
Pharmaceutical Industry
Scientific Societies
Universities and Training Schools
Other Collaborations
PUBLICATIONS
Therapeutic Area
Project Type
Papers
Abstracts
Books
TRAINING
BROCHURES
Corporate Brochure
Health Outcomes Research Brochure
Economic Evaluation Brochure
Statistical Evidence Brochure
en
es
NOTICIAS PORIB
News
Valor clínico y económico de la estrategia ReLink-C
Leer más »
9 July 2021
News
PORIB ha estado presente en el ILC Congress con 2 Comunicaciones
Leer más »
7 July 2021
News
SOF reduce la carga de la enfermedad y la mortalidad por causa hepática
Leer más »
5 July 2021
News
Efectos negativos de la COVID-19 en el VHC
Leer más »
29 June 2021
News
Tratamiento para Leucemia Mieloide Aguda más eficiente para el SNS
Leer más »
15 June 2021
News
PORIB vuelve a obtener un sobresaliente en Calidad y Servicios
Leer más »
25 May 2021
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
Page
13
Page
14
Page
15
Page
16
Page
17
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Page
24
Page
25
Page
26
Page
27
Page
28
Page
29
Page
30
Page
31
Page
32
Page
33
Page
34
Page
35
Page
36
Page
37
Page
38
Page
39
